CTRI/2018/02/011782CompletedPhase 2
Clinical evaluation of Haridrakhand and Triphala Kwath in the management of Chronic AllergicConjunctivitis (Kaphaja Abhishandya) - HATAC
Central Council for Research in Ayurvedic Sciences0 sites55 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 55
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.Patients of either sex with age between 18
- •and 60 years.
- •2.Patients presenting with signs and symptoms
- •of Chronic Allergic Conjunctivitis having
- •history of seasonal or perennial allergic
- •conjunctivitis for at least 1 year on the
- •basis of following objective and subjective
- •parameters i.e.-Redness,Itching,Lacrimation,
- •Photophobia,FB Sensation,Burning
- •Sensation,Lid Swelling
- •3. Patients willing to participate and give
- •written informed consent to participate in
- •the study for 10 weeks including 2 weeks
- •without drug follow-up
Exclusion Criteria
- •1. Patients having associated marginal corneal
- •ulcer, Dacryocystitis, Trachoma, Kerato-
- •Conjunctivitis, infective conjunctivitis,
- •allergic to dyes and seborrhic Blepharitis,
- •dandruffs etc.
- •2. Patients positive for conjunctival smear and
- •culture to exclude any infective occurrence.
- •3. Patients with concurrent serious hepatic
- •disorder (defined as Aspartate Amino
- •Transferase (AST) and / or Alanine Amino
- •Transferase (ALT), Total Bilirubin, Alkaline
- •Phosphatase (ALP) > 2 times upper normal
- •4. Patients having serious Renal Dysfunction,
- •uncontrolled Pulmonary Dysfunction,
- •(asthmatic and COPD patients) or other
- •concurrent severe disease.
- •5. Patients with uncontrolled Diabetes Mellitus
- •(Blood Sugar Fasting > 250 mg/dl)
- •6. Patients with poorly controlled Hypertension
- •( > 160/100 mmHg).
- •7. Pregnant / lactating females.
- •8. Patients on steroids, oral contraceptives,
- •or estrogen replacement therapy.
- •9. Smokers/Alcoholics and/or drug abusers.
- •10. Patients suffering from major systemic
- •illness necessitating long term drug
- •treatment (Rheumatoid arthritis, Psycho-
- •Neuro - Endocrinal disorders, etc.).
- •11. H/o hypersensitivity to the trial drug or
- •any of its ingredients.
- •12. Patients who have completed participation
- •in any other clinical trial during the past
- •six months.
- •13. Any other condition which the Investigator
- •thinks may jeopardize the study.
Investigators
Similar Trials
Not yet recruiting
Phase 2
A clinical study to see the effect of some Ayurvedic formulations in the management of Chronic Allergic ConjunctivitisCTRI/2016/04/006869Central Council for Research in Ayurvedic Sciences55
Recruiting
Phase 2
A clinical study to see the effect of some Ayurvedic formulations in the management of Bronchial AsthmaCTRI/2016/04/006801Central Council for Research in Ayurvedic Sciences210
Not yet recruiting
Phase 2
Role of khadirastak kwatha and manjisthadi taila(external application) in treatment of psoriasisCTRI/2024/04/065046J S Ayurved Mahavidhyalay
Not yet recruiting
Phase 2
TO OBSERVE THE EFFECT OF AYURVEDIC MEDICINE FOR THE TREATMENT OF KASA (STABLE CHRONIC BRONCHITIS)CTRI/2019/07/020214Central Council for Research in Ayurvedic Sciences
Active, not recruiting
Phase 3
A clinical study on Bronchial Asthma in childreCTRI/2016/05/006971Director IPGT RA GAU JAMNAGAR30